ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0798

A Novel 3D Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells and Macrophages

Eva Philippon1, Lisanne van Rooijen1, Jan Piet van Hamburg1, Fatemeh Khodadust1, Conny Van der Laken2 and Sander Tas3, 1Amsterdam University Medical Centers, Amsterdam, Netherlands, 2Amsterdam UMC - location VUMC, Amsterdam, Netherlands, 3Amsterdam UMC, locatie AMC, Utrecht, Netherlands

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Fibroblasts, Synovial, macrophages, rheumatoid arthritis, Structure

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: RA – Animal Models

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Rheumatoid Arthritis (RA) is a progressive and systemic autoimmune disorder associated with chronic and destructive inflammation of the joints. The hallmarks of RA are synovial cell proliferation, extensive neoangiogenesis and infiltration of numerous immune cells into the synovial tissue. In vitro approaches simulating RA synovial tissue are crucial in preclinical and translational research to expand our knowledge on RA human pathophysiology and to test new diagnostic and therapeutic applications. Here, we present the engineering of a spheroid-based model of RA synovial tissue which mimics the close interaction between cells and key pro-inflammatory mediators present in the inflamed synovium.

Methods: Monocyte-derived macrophages were cultured at different concentrations with RA fibroblast-like-synoviocytes (RAFLS) and endothelial cells (ECs) for 24 hours to allow for spheroid formation. Then, the spheroids were placed in a collagen-based matrix for 40 hours to study spheroid outgrowth in 3 dimensions. The spheroids were left unstimulated, or cultured in the presence of growth factors VEGF/bFGF or RA synovial fluid (SF). Spheroid outgrowth and cell migration were quantified for all conditions using confocal microscopy and a new quantification approach by machine learning (QuPath).

Results: Addition of macrophages to the previously established 3D model of RA angiogenesis consisting of ECs and RAFLS resulted in close interaction of macrophages with RAFLS and ECs within the spheroid structure. The number of macrophages that migrated out from the core increased with the initial macrophage input while slightly promoting spheroid outgrowth. The optimal ratio between RA-FLS, ECs and macrophages in our system was established accordingly as 1:2:0.8. Addition of growth factors (VEGF/bFGF) significantly promoted spheroid outgrowth compared to the unstimulated condition in the new model (p< 0.05). The presence of SF significantly enhanced cell containment of the ECs and macrophages within the core (p< 0.05).

Conclusion: We present a novel 3D-spheroid based model consisting of RA-FLS, ECs and macrophages that mimics the RA synovial tissue microenvironment. This model is useful to dissect the role of specific cell types in inflammatory responses in RA, to study specific signaling pathways involved in the disease pathogenesis and examine the potential of novel diagnostic (molecular imaging) and therapeutic compounds, including small molecule inhibitors and biologics.

Supporting image 1

Representative confocal Z-stack projection pictures of the 3D model containing 3.75×10^4 RAFLS (magenta), 7.5×10^4 EC (cyan) and 3.0×10^4 macrophages (yellow). Spheroids were left either unstimulated (UNSTIM.), stimulated with VEGF/bFGF (10 ng/ml) or SF (20%). VEGF/bFGF induces spheroid outgrowth in the new 3D model containing macrophages, whereas RASF enhances macrophage containment and compaction.


Disclosures: E. Philippon: None; L. van Rooijen: None; J. van Hamburg: None; F. Khodadust: None; C. Van der Laken: None; S. Tas: None.

To cite this abstract in AMA style:

Philippon E, van Rooijen L, van Hamburg J, Khodadust F, Van der Laken C, Tas S. A Novel 3D Model of Rheumatoid Arthritis Synovial Tissue Incorporating Fibroblasts, Endothelial Cells and Macrophages [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-novel-3d-model-of-rheumatoid-arthritis-synovial-tissue-incorporating-fibroblasts-endothelial-cells-and-macrophages/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-novel-3d-model-of-rheumatoid-arthritis-synovial-tissue-incorporating-fibroblasts-endothelial-cells-and-macrophages/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology